1155 related articles for article (PubMed ID: 25886386)
1. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of Astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats.
Ju Y; Su Y; Chen Q; Ma K; Ji T; Wang Z; Li W; Li W
Biomed Pharmacother; 2019 Jan; 109():84-92. PubMed ID: 30396095
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats.
Chen Y; Gui D; Chen J; He D; Luo Y; Wang N
Cell Physiol Biochem; 2014; 33(6):1975-87. PubMed ID: 25012492
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
5. Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy.
Tian N; Gao Y; Wang X; Wu X; Zou D; Zhu Z; Han Z; Wang T; Shi Y
Drug Des Devel Ther; 2018; 12():2195-2211. PubMed ID: 30034224
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.
Guo H; Wang Y; Zhang X; Zang Y; Zhang Y; Wang L; Wang H; Wang Y; Cao A; Peng W
Sci Rep; 2017 Jul; 7(1):6852. PubMed ID: 28761152
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway.
Lei X; Zhang BD; Ren JG; Luo FL
Life Sci; 2018 Aug; 206():77-83. PubMed ID: 29792879
[TBL] [Abstract][Full Text] [Related]
9. Grape seed proanthocyanidins protect against streptozotocin‑induced diabetic nephropathy by attenuating endoplasmic reticulum stress‑induced apoptosis.
Gao Z; Liu G; Hu Z; Shi W; Chen B; Zou P; Li X
Mol Med Rep; 2018 Aug; 18(2):1447-1454. PubMed ID: 29901130
[TBL] [Abstract][Full Text] [Related]
10. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L
J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats.
Lei X; Zhang L; Li Z; Ren J
Drug Des Devel Ther; 2018; 12():2785-2793. PubMed ID: 30233141
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression.
Gui D; Huang J; Guo Y; Chen J; Chen Y; Xiao W; Liu X; Wang N
Cytokine; 2013 Mar; 61(3):970-7. PubMed ID: 23434274
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation.
Zhang Y; Tao C; Xuan C; Jiang J; Cao W
Oxid Med Cell Longev; 2020; 2020():9542165. PubMed ID: 32855769
[TBL] [Abstract][Full Text] [Related]
14. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation.
Luo ZF; Feng B; Mu J; Qi W; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):49-57. PubMed ID: 20399799
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of resveratrol on kidney in rats with diabetic nephropathy and its effect on endoplasmic reticulum stress.
Yuan D; Liu XM; Fang Z; Du LL; Chang J; Lin SH
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1485-1493. PubMed ID: 29565511
[TBL] [Abstract][Full Text] [Related]
16. Involvement of glucose-regulated protein 78 and spliced X-box binding protein 1 in the protective effect of gliclazide in diabetic nephropathy.
Zhang YW; Wang X; Ren X; Zhang M
Diabetes Res Clin Pract; 2018 Dec; 146():41-47. PubMed ID: 28951332
[TBL] [Abstract][Full Text] [Related]
17. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J; Miao JJ; Sun XY; Yu JY
J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice.
Song G; Han P; Sun H; Shao M; Yu X; Wang W; Wang D; Yi W; Ge N; Li S; Yi T
J Int Med Res; 2018 Jul; 46(7):2883-2897. PubMed ID: 29896981
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
Zhang C; Li Q; Lai S; Yang L; Shi G; Wang Q; Luo Z; Zhao R; Yu Y
J Ethnopharmacol; 2017 Jun; 205():207-216. PubMed ID: 28501426
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response.
Qi W; Mu J; Luo ZF; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH; Feng B
Metabolism; 2011 May; 60(5):594-603. PubMed ID: 20817186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
